ncDR

LncRNA	Compound	Cancer	P-value	Effect
ENSG00000255992.1	ABT-263 (navitoclax)	Chronic Lymphocytic Leukemia	0.025452817	Resistant
ENSG00000255992.1	ABT-263 (navitoclax)	Lung squamous cell carcinoma	0.015821854	Resistant